glycopyrronium bromide (Sialanar) For symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.
glycopyrronium (Seebri Breezhaler) For a once daily maintenance bronchodilator treatment to relieve symptoms in patients with COPD.
glycopyrronium/formoterol fumarate (Bevespi Aerosphere) Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
indacaterol/glycopyrronium/mometasone furoate (Enerzair Breezhaler) As a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
glycopyrronium/formoterol fumarate dihydrate (Bevespi Aerosphere) Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.
indacaterol maleate, glycopyrronium bromide (Ultibro Breezhaler) maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
formoterol fumarate dihydrate/glycopyrronium/budesonide (Trixeo Aerosphere) Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long‑acting beta2‑agonist or combination of a long-acting beta2‑agonist and a long‑acting muscarinic antagonist.
beclometasone dipropionate/formoterol fumarate dehydrate/glycopyrronium bromide (Trimbow) Maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
beclometasone dipropionate/formoterol fumarate dehydrate/glycopyrronium bromide (Trimbow) Maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
beclometasone dipropionate anhydrous/formoterol fumarate dihydrate/glycopyrronium bromide (Trimbow) Maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist.
April 2024 decisions news release The Scottish Medicines Consortium (SMC), which advises on newly-licensed medicines for use by NHSScotland, has today (Monday, March 11) published advice on seven medicines.
